Martin-Herranz · Genome biology 2019 · Case-control observational study · n=?

Screening for genes that accelerate the epigenetic aging clock in humans reveals a role for the H3K36 methyltransferase NSD1.

Cited 125 times in the scientific literature.

Level 4 - case-series / case-control

Case-control observational study analyzing blood DNA methylation in patients with genetic disorders

PubMed 31409373 · doi:10.1186/s13059-019-1753-9 · record verified 2026-08-30

What was done

The authors screened for epigenetic age acceleration in the blood of patients with various developmental disorders caused by mutations in epigenetic regulatory machinery. DNA methylation patterns were evaluated using the Horvath epigenetic aging clock to identify specific gene disruptions affecting the rate of biological aging, with focused profiling on patients carrying loss-of-function mutations in the NSD1 histone methyltransferase gene (Sotos syndrome) and analyses of Shannon methylation entropy across clock CpG sites.

What was found

The abstract reports no specific sample sizes, numerical effect sizes, or p-values. Loss-of-function mutations in the H3K36 methyltransferase NSD1 were reported to substantially accelerate Horvath epigenetic aging. Normal aging and Sotos syndrome shared DNA methylation alterations and genomic contexts. Additionally, Horvath clock CpG sites exhibited higher baseline Shannon methylation entropy than the rest of the genome, which was markedly decreased in patients with Sotos syndrome.

Why it matters

This study identifies a specific molecular pathway—the H3K36 histone methylation machinery regulated by NSD1—as an intrinsic modulator of the human epigenetic clock, providing mechanistic insight into how chromatin maintenance systems influence biological aging rates.

Limits

The abstract omits sample sizes, patient demographics, control cohort details, and quantitative estimates of age acceleration. Findings are limited to blood tissue and observational genetic disruption phenotypes, which may reflect developmental dysregulation rather than typical physiological aging mechanisms.

Cited by